ALC logo

Alcon Inc. Stock Price

SWX:ALC Community·CHF 31.2b Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 26 Fair Values set on narratives written by author

ALC Share Price Performance

CHF 63.54
-14.08 (-18.14%)
CHF 79.92
Fair Value
CHF 63.54
-14.08 (-18.14%)
20.5% undervalued intrinsic discount
CHF 79.92
Fair Value
Price CHF 63.54
AnalystConsensusTarget CHF 79.92
AnalystLowTarget CHF 62.32
AnalystHighTarget CHF 98.45

ALC Community Narratives

AnalystConsensusTarget·
Fair Value CHF 79.92 20.5% undervalued intrinsic discount

Cutting Edge Eye Care Solutions Will Transform Outcomes For Global Aging Populations

0users have liked this narrative
0users have commented on this narrative
17users have followed this narrative
AnalystLowTarget·
Fair Value CHF 62.32 2.0% overvalued intrinsic discount

Government Price Cuts Will Compress Margins Though Telemedicine Supports

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AnalystHighTarget·
Fair Value CHF 98.45 35.5% undervalued intrinsic discount

Unity VCS And LumiThera Will Drive Global Eye Care Transformation

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
CHF 98.45
35.5% undervalued intrinsic discount
Revenue growth
9.12% p.a.
Profit Margin
15.8%
Future PE
33.88x
Share price in 2028
CHF 112.89
CHF 62.32
2.0% overvalued intrinsic discount
AnalystLowTarget Fair Value
Revenue growth
6.56% p.a.
Profit Margin
12.34%
Future PE
29.48x
Share price in 2028
CHF 71.49

Updated Narratives

ALC logo

Cutting Edge Eye Care Solutions Will Transform Outcomes For Global Aging Populations

Fair Value: CHF 79.92 20.5% undervalued intrinsic discount
17 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
ALC logo

Government Price Cuts Will Compress Margins Though Telemedicine Supports

Fair Value: CHF 62.32 2.0% overvalued intrinsic discount
0 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
ALC logo

Unity VCS And LumiThera Will Drive Global Eye Care Transformation

Fair Value: CHF 98.45 35.5% undervalued intrinsic discount
0 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Excellent balance sheet and good value.

0 Risks
3 Rewards

Alcon Inc. Key Details

US$10.2b

Revenue

US$4.5b

Cost of Revenue

US$5.7b

Gross Profit

US$4.6b

Other Expenses

US$1.0b

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
2.13
55.57%
10.28%
21.4%
View Full Analysis

About ALC

Founded
1945
Employees
25000
CEO
David Endicott
WebsiteView website
www.alcon.com

Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. It operates through two segments, Surgical and Vision Care. The company offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. Its cataract products include Centurion vision system, LenSx laser system, Verion reference unit and Verion digital marker, ARGOS biometer, SMARTCATARACT health platform, NGENUITY 3D visualization system, LuxOR surgical ophthalmic microscope, and ORA system for intra-operative measurements; and implantable products, including monofocal, Toric, and Presbyopia-Correcting IOLs, as well as delivery systems, such as AutonoMe and UltraSert. In addition, it provides Custom Pak surgical procedure packs vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, grieshaber, MIVS instruments, scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit vitrectomy probes; and refractive surgery products, including WaveLight and Contoura Vision used for LASIK refractive procedure. Further, the company offers daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, ocular allergies, glaucoma, and contact lens care, as well as ocular vitamins and redness relievers. The company was formerly known as Alcon Universal S.A. and changed its name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.

Recent ALC News & Updates

Alcon Inc. (VTX:ALC) Third-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For Next Year

Nov 14
Alcon Inc. (VTX:ALC) Third-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For Next Year

Recent updates

No updates